Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm

Accueil Connaissances Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm

Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm

The aim of this study was to assess and compare the safety and efficacy performance of two commercial vaccines registered in Canada, under field conditions, on a commercial farm where E. coli was found to be the source of diarrhea.

À propos de cet article

Paru dans

AASV Congress, 2017

Auteurs

Ariza, W.; Robles, D.; Badia, J.; Torrents, D.; Bernal, I.

Résumé

Neonatal diarrhea currently continues to be one of the pathologies that has the highest cost for producers and E. coli is still one of the primary triggers among the infectious agents that cause neonatal diarrhea in pigs. The current study shows differing diarrhea-preventive effects of the two vaccines evaluated. Thus, Vaccine A (SUISENG®) exhibited a 6-fold lower incidence of diarrhea in suckling piglets from gilts vaccinated with it than in suckling piglets from gilts vaccinated with its competitor, Vaccine B. Moreover, Vaccine A (SUISENG®) showed greater safety than Vaccine B by causing a smaller increase in post-vaccination body temperature and by not showing any local or general type reactions, which may end in abortion and the resultant economic loss to the producer.

Produits liés

Partager

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}